Soziologie
New Paper on a Debated Parenting Practice in the Journal of Cognitive Enhancement by Sebastian Sattler
Hiltrop, K., Sattler, S.
(2022, online first): Parents’ Perceptions on the Debated Parenting
Practice of Cognitive Enhancement in Healthy Children and Adolescents. Journal of Cognitive Enhancement (shared
1st authorship). ►LINK
Parents’
Perceptions on the Debated Parenting Practice of Cognitive Enhancement in
Healthy Children and Adolescents
Abstract
First evidence shows that some
parents engage in the health-endangering practice of (mis-)using prescription
drugs to boost their children’s school performance. But little is known about
parental perspectives on this phenomenon. This study aims to better understand
parents’ perspectives on the non-medical use of prescription drugs to improve
healthy children’s cognitive functioning. We conducted twelve semi-structured
face-to-face interviews with a diverse sample of parents in Germany, and
applied qualitative content analysis to explore their perspectives on
instrumentalizing prescription drugs for improving the performance of healthy
children, including their underlying knowledge (gaps), moral evaluations,
evaluations of accompanied risks and benefits, opinions on potential
motivators, and wishes regarding policy-making. The results show that parents typically
believed themselves knowledgeable about such prescription drug (mis-)use,
although they were not aware of anyone in their social environment taking them
for enhancement. Parents generally considered such behavior to be morally
reprehensible, cheating, and similar to doping in sports, and they typically
claimed that no situation or occasion could motivate them to administer
prescription drugs to their healthy children. Health risks (including side
effects or addiction) were a typical expectation of drug use. That doctors
should give such drugs to healthy young people was seen as unjustifiable. The
results suggest that morality and risk–benefit evaluations of parents play a
major role in their decision-making concerning this potentially risky instrumentalization
of non-medical drugs. These insights are of distinct importance, especially for
future research and further discussions on this topic, such as an
evidence-based public dialog and ethics debates.